Table: Hisamitsu -2023/24 parent results
Apr 11 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Feb 29, 2024 Feb 28, 2023 Feb 28, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 96.65 92.98
(+3.9 pct) (+2.6 pct)
Operating 10.70 10.85
(-1.3 pct) (+25.9 pct)
Recurring 14.23 14.06
(+1.2 pct) (+32.5 pct)
Net 9.86 10.41
(-5.4 pct) (+45.3 pct)
EPS 128.08 yen 131.21 yen
EPS Diluted 127.93 yen 131.10 yen
Ann Div 85.00 yen 84.50 yen 90.00 yen
-Q2 Div 42.50 yen 42.25 yen 45.00 yen
-Q4 Div 42.50 yen 42.25 yen 45.00 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO